Stock Ticker

  • Loading stock data...

Is It Time To Buy Keryx Biopharmaceuticals (NASDAQ:KERX)?

Boston, MA 08/29/2014 (wallstreetpr) – Several analysts are giving a second thought on their ratings on Keryx Biopharmaceuticals (NASDAQ:KERX). Maxim Group has got a “buy” rating on Keryx stocks. FBR Capital Markets have got a “market perform” rating on Keryx with a price target of $16.00. As of now, Keryx shares are trading well above their […]

Shareholder Breakfast: IsoRay, Inc. (NYSEMKT:ISR), 22nd Century Group Inc (NYSEMKT:XXII), Keryx Biopharmaceuticals (NASDAQ:KERX)

Boston, MA 03/27/2014 (wallstreetpr) – IsoRay, Inc. (NYSEMKT:ISR) edged up Wednesday, managing to recover from the Friday fall occasioned by announced shares dilution. The stock jumped 12.62 percent to settle at $2.32. In order to raise funds for working capital and corporate purposes, the company announced that it was offering common stock shares directly to […]

Keryx Biopharmaceuticals (NASDAQ:KERX) Rallies After Price Target Upgrades

Boston, MA 10/21/2013 (wallstreetpr) – Investors of Keryx Biopharmaceuticals (NASDAQ:KERX) have nothing to complain about during the last week. The shares of company have rallied from low of $8.7 to highs of $11.90 giving a return of more than 36% in less than 5 days. But it does seem that current rally may not sustain for long […]

Sign Up To Get Our Latest Stocks Alerts